Exclusive: Europe to accelerate trials of gene-engineered COVID-19 vaccines - sources

Reuters India

10 Jun 2020 0 shares 1 views

Exclusive: Europe to accelerate trials of gene-engineered COVID-19 vaccines - sources

Reuters India

Published 10 Jun 2020

European officials aim to speed up trials for coronavirus vaccines containing genetically modified organisms, two EU sources told Reuters, in a move that could help shots developed by companies like AstraZeneca and Johnson & Johnson.

Full Article

Related news coverage

We got an exclusive look at the pitch deck BrightInsight used to raise $40 million by convincing investors that it can help Big Pharma go digital

· BrightInsight just raised $40 million for its tech-savvy tools that help drugmakers get their treatments and devices over the..

Business Insider 23 Jun 2020

NA Proactive news snapshot: BevCanna Enterprises, Cabral Gold, VR Resources, The Valens Company, Metalla Royalty & Streaming, Namaste Technologies UPDATE …

BevCanna Enterprises Inc (CSE:BEV) (OTCMKTS:BVNNF) said Monday that it has completed the acquisition of privately owned Exceler..

Proactive Investors 22 Jun 2020

Exclusive: Europe to accelerate trials of gene-engineered COVID-19 vaccines - sources

Exclusive: Europe to accelerate trials of gene-engineered COVID-19 vaccines - sources

You might like

Related news coverage

We got an exclusive look at the pitch deck BrightInsight used to raise $40 million by convincing investors that it can help Big Pharma go digital

NA Proactive news snapshot: BevCanna Enterprises, Cabral Gold, VR Resources, The Valens Company, Metalla Royalty & Streaming, Namaste Technologies UPDATE …

Advertisement